Serveur d'exploration sur le confinement (PubMed)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment.

Identifieur interne : 002622 ( Main/Corpus ); précédent : 002621; suivant : 002623

A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment.

Auteurs : Manish Kumar ; Kaling Taki ; Rohit Gahlot ; Ayushi Sharma ; Kiran Dhangar

Source :

RBID : pubmed:32434058

English descriptors

Abstract

In order to benefit the public, community workers and scientific community, we hereby present a chronicle of SARS-CoV-2 that leads to the unseen precedent of social distancing and lockdown owing to coronavirus disease (COVID-19). Information on this life-threatening pandemic of COVID-19 is sparse and discrete; and the urgency is such that the dissemination of information is increasing with numerous daily publications on the topic. Therefore, we developed a comprehensive review on various aspects of SARS-CoV-2 and COVID-19. We scientifically compiled published research, news, and reports from various sources to comprehend and summarize the information and findings on Coronaviruses. The review explicitly covers the aspects like genome and pedigree of SARS-CoV-2; epidemiology, prognosis, pathogenesis, symptoms and diagnosis of COVID-19 in order to catalog the right information on transmission route, and influence of environmental factors on virus transmissions, for the robust understanding of right strategical steps for proper COVID-19 management. We have explicitly highlighted several useful information and facts like: i) No established relationship between progression of SARS-CoV-2 with temperature, humidity and/or both, ii) The underlying mechanism of SARS-CoV-2 is not fully understood, iii) Respiratory droplet size determines drop and airborne-based transmission, iv) Prognosis of COVID-19 can be done by its effects on various body organs, v) Infection can be stopped by restricting the binding of S protein and AE2, vi) Hydroxychloroquine is believed to be better than chloroquine for COVID-19, vii) Ivermectin with Vero-hSLAM cells is able to reduce infection by ~5000 time within 2 days, and viii) Nafamostat mesylate can inhibit SARS-CoV-2 S protein-initiated membrane fusion. We have also suggested future research perspectives, challenges and scope.

DOI: 10.1016/j.scitotenv.2020.139278
PubMed: 32434058
PubMed Central: PMC7227583

Links to Exploration step

pubmed:32434058

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment.</title>
<author>
<name sortKey="Kumar, Manish" sort="Kumar, Manish" uniqKey="Kumar M" first="Manish" last="Kumar">Manish Kumar</name>
<affiliation>
<nlm:affiliation>Discipline of Earth Sciences, Indian Institute of Technology Gandhinagar, Gujarat 382355, India. Electronic address: manish.kumar@iitgn.ac.in.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taki, Kaling" sort="Taki, Kaling" uniqKey="Taki K" first="Kaling" last="Taki">Kaling Taki</name>
<affiliation>
<nlm:affiliation>Discipline of Civil Engineering, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gahlot, Rohit" sort="Gahlot, Rohit" uniqKey="Gahlot R" first="Rohit" last="Gahlot">Rohit Gahlot</name>
<affiliation>
<nlm:affiliation>Discipline of Materials Science and Engineering, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sharma, Ayushi" sort="Sharma, Ayushi" uniqKey="Sharma A" first="Ayushi" last="Sharma">Ayushi Sharma</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Vallabhbhai Patel Chest Institute (VPCI), Delhi University, Delhi 110007, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dhangar, Kiran" sort="Dhangar, Kiran" uniqKey="Dhangar K" first="Kiran" last="Dhangar">Kiran Dhangar</name>
<affiliation>
<nlm:affiliation>Discipline of Earth Sciences, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32434058</idno>
<idno type="pmid">32434058</idno>
<idno type="doi">10.1016/j.scitotenv.2020.139278</idno>
<idno type="pmc">PMC7227583</idno>
<idno type="wicri:Area/Main/Corpus">002622</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">002622</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment.</title>
<author>
<name sortKey="Kumar, Manish" sort="Kumar, Manish" uniqKey="Kumar M" first="Manish" last="Kumar">Manish Kumar</name>
<affiliation>
<nlm:affiliation>Discipline of Earth Sciences, Indian Institute of Technology Gandhinagar, Gujarat 382355, India. Electronic address: manish.kumar@iitgn.ac.in.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taki, Kaling" sort="Taki, Kaling" uniqKey="Taki K" first="Kaling" last="Taki">Kaling Taki</name>
<affiliation>
<nlm:affiliation>Discipline of Civil Engineering, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gahlot, Rohit" sort="Gahlot, Rohit" uniqKey="Gahlot R" first="Rohit" last="Gahlot">Rohit Gahlot</name>
<affiliation>
<nlm:affiliation>Discipline of Materials Science and Engineering, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sharma, Ayushi" sort="Sharma, Ayushi" uniqKey="Sharma A" first="Ayushi" last="Sharma">Ayushi Sharma</name>
<affiliation>
<nlm:affiliation>Department of Pharmacology, Vallabhbhai Patel Chest Institute (VPCI), Delhi University, Delhi 110007, India.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dhangar, Kiran" sort="Dhangar, Kiran" uniqKey="Dhangar K" first="Kiran" last="Dhangar">Kiran Dhangar</name>
<affiliation>
<nlm:affiliation>Discipline of Earth Sciences, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Science of the total environment</title>
<idno type="eISSN">1879-1026</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Humans (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>Pneumonia, Viral (transmission)</term>
<term>Prognosis (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Spike Glycoprotein, Coronavirus (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Prognosis</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In order to benefit the public, community workers and scientific community, we hereby present a chronicle of SARS-CoV-2 that leads to the unseen precedent of social distancing and lockdown owing to coronavirus disease (COVID-19). Information on this life-threatening pandemic of COVID-19 is sparse and discrete; and the urgency is such that the dissemination of information is increasing with numerous daily publications on the topic. Therefore, we developed a comprehensive review on various aspects of SARS-CoV-2 and COVID-19. We scientifically compiled published research, news, and reports from various sources to comprehend and summarize the information and findings on Coronaviruses. The review explicitly covers the aspects like genome and pedigree of SARS-CoV-2; epidemiology, prognosis, pathogenesis, symptoms and diagnosis of COVID-19 in order to catalog the right information on transmission route, and influence of environmental factors on virus transmissions, for the robust understanding of right strategical steps for proper COVID-19 management. We have explicitly highlighted several useful information and facts like: i) No established relationship between progression of SARS-CoV-2 with temperature, humidity and/or both, ii) The underlying mechanism of SARS-CoV-2 is not fully understood, iii) Respiratory droplet size determines drop and airborne-based transmission, iv) Prognosis of COVID-19 can be done by its effects on various body organs, v) Infection can be stopped by restricting the binding of S protein and AE2, vi) Hydroxychloroquine is believed to be better than chloroquine for COVID-19, vii) Ivermectin with Vero-hSLAM cells is able to reduce infection by ~5000 time within 2 days, and viii) Nafamostat mesylate can inhibit SARS-CoV-2 S protein-initiated membrane fusion. We have also suggested future research perspectives, challenges and scope.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">32434058</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>06</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1879-1026</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>734</Volume>
<PubDate>
<Year>2020</Year>
<Month>Sep</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>The Science of the total environment</Title>
<ISOAbbreviation>Sci Total Environ</ISOAbbreviation>
</Journal>
<ArticleTitle>A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment.</ArticleTitle>
<Pagination>
<MedlinePgn>139278</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0048-9697(20)32795-9</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2020.139278</ELocationID>
<Abstract>
<AbstractText>In order to benefit the public, community workers and scientific community, we hereby present a chronicle of SARS-CoV-2 that leads to the unseen precedent of social distancing and lockdown owing to coronavirus disease (COVID-19). Information on this life-threatening pandemic of COVID-19 is sparse and discrete; and the urgency is such that the dissemination of information is increasing with numerous daily publications on the topic. Therefore, we developed a comprehensive review on various aspects of SARS-CoV-2 and COVID-19. We scientifically compiled published research, news, and reports from various sources to comprehend and summarize the information and findings on Coronaviruses. The review explicitly covers the aspects like genome and pedigree of SARS-CoV-2; epidemiology, prognosis, pathogenesis, symptoms and diagnosis of COVID-19 in order to catalog the right information on transmission route, and influence of environmental factors on virus transmissions, for the robust understanding of right strategical steps for proper COVID-19 management. We have explicitly highlighted several useful information and facts like: i) No established relationship between progression of SARS-CoV-2 with temperature, humidity and/or both, ii) The underlying mechanism of SARS-CoV-2 is not fully understood, iii) Respiratory droplet size determines drop and airborne-based transmission, iv) Prognosis of COVID-19 can be done by its effects on various body organs, v) Infection can be stopped by restricting the binding of S protein and AE2, vi) Hydroxychloroquine is believed to be better than chloroquine for COVID-19, vii) Ivermectin with Vero-hSLAM cells is able to reduce infection by ~5000 time within 2 days, and viii) Nafamostat mesylate can inhibit SARS-CoV-2 S protein-initiated membrane fusion. We have also suggested future research perspectives, challenges and scope.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>Manish</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Discipline of Earth Sciences, Indian Institute of Technology Gandhinagar, Gujarat 382355, India. Electronic address: manish.kumar@iitgn.ac.in.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taki</LastName>
<ForeName>Kaling</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Discipline of Civil Engineering, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gahlot</LastName>
<ForeName>Rohit</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Discipline of Materials Science and Engineering, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharma</LastName>
<ForeName>Ayushi</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacology, Vallabhbhai Patel Chest Institute (VPCI), Delhi University, Delhi 110007, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dhangar</LastName>
<ForeName>Kiran</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Discipline of Earth Sciences, Indian Institute of Technology Gandhinagar, Gujarat 382355, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>05</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Sci Total Environ</MedlineTA>
<NlmUniqueID>0330500</NlmUniqueID>
<ISSNLinking>0048-9697</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">MERS-CoV</Keyword>
<Keyword MajorTopicYN="N">Pathogenesis</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Transmission</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>05</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>05</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>6</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32434058</ArticleId>
<ArticleId IdType="pii">S0048-9697(20)32795-9</ArticleId>
<ArticleId IdType="doi">10.1016/j.scitotenv.2020.139278</ArticleId>
<ArticleId IdType="pmc">PMC7227583</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2020 Feb 20;382(8):760-762</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31978944</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Apr 16;382(16):1564-1567</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32182409</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 22;395(10224):542-545</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32061313</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chem. 2020 Apr 1;66(4):549-555</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32031583</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2003 Oct;41(10):4521-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14532176</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 2013 Nov;193(2):337-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23811231</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiographics. 2004 Mar-Apr;24(2):553-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15026600</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2019 May 28;116(22):10905-10910</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31085641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32085846</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15616839</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mil Med Res. 2020 Mar 13;7(1):11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32169119</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Feb 25;323(8):709-710</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31999307</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Jul;88(14):7692-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24789791</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J R Soc Interface. 2009 Dec 6;6 Suppl 6:S783-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19773292</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2006 May 29;3:39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16729896</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3645-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19276125</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2004 Sep 15;160(6):509-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15353409</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Cent Sci. 2020 Mar 25;6(3):315-331</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32226821</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 2013 Nov;193(2):653-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23928222</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12682352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>West J Emerg Med. 2015 Sep;16(5):619-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26587081</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Microbiol Infect Dis. 2005 Sep;24(9):583-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16172857</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2020 Jan;14(1):11-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31631558</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharm Anal. 2020 Apr;10(2):102-108</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32282863</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2016 Oct 3;16(1):534</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27716101</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 28;71(15):762-768</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32161940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2019 May 27;16(1):69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31133031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2015 Jan 1;211(1):80-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25030060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2017 Mar 06;7:43395</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28262699</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Environ Res. 2020 Apr;183:109179</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32006770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1960 Oct 29;188:430-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13713229</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2019 Jan 31;19(1):101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30704406</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diagnostics (Basel). 2020 Apr 05;10(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32260471</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2011 Feb;85(3):1400-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21084485</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Apr 14;323(14):1406-1407</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32083643</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Environ Res. 2020 Jul;186:109553</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32330766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AJR Am J Roentgenol. 2020 Jun;214(6):1280-1286</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32130038</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23486063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Otolaryngol. 2002 Mar;122(2):183-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11936911</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Infect Control. 2006 May;34(4):234-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16679182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2018 Oct 5;362(6410):75-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30287659</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Nano. 2020 Feb 25;14(2):2497-2508</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32045522</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2008 Apr;133(1):13-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17374415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2013 Sep;13(9):752-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23891402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Virol. 2011;2011:734690</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22312351</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Total Environ. 2020 Oct 15;739:139076</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32758929</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2004 Jul;10(7):676-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15214887</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Groundw Sustain Dev. 2020 Oct;11:100400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32322654</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2020 Jun 2;172(11):754-755</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32232419</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 2007 May;141(2):173-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17218021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Mar 19;382(12):1177-1179</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32074444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2020 Jun;178:104787</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32251768</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Total Environ. 2019 Nov 25;693:133640</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31377355</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Microbiol. 2016 Jun;24(6):490-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27012512</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2009 Jun;7(6):439-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19430490</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>mBio. 2012 Nov 20;3(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23170002</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AJR Am J Roentgenol. 2016 Jun;206(6):1193-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26998804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32064853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Microbiol. 2020 Apr;5(4):536-544</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32123347</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2011 Sep;11(9):677-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21550310</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32253318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2020 Mar 11;27(3):325-328</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32035028</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3243-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19204283</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Public Health. 2020 Apr 24;8:163</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32391310</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Biotechnol. 2010 Jun;28(6):595-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20495550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1999 Apr;37(4):937-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10074505</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cyst Fibros. 2008 Jul;7(4):320-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18255355</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 28;71(15):841-843</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32047895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiology. 2020 Aug;296(2):E32-E40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32101510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Investig Med. 2011 Aug;59(6):881-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21527855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Microbiol. 2013 Oct;21(10):544-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23770275</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Radiol. 2020 Jun;30(6):3306-3309</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32055945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Jun;55(6):105948</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32201353</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 2007 Jan;139(1):78-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17052763</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32105090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2017 Sep 27;9(409):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28954927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiology. 2020 Jun;295(3):715-721</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32053470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Differ. 2020 May;27(5):1451-1454</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32205856</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chin Med J (Engl). 2020 May 5;133(9):1025-1031</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32044814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Mar;579(7798):265-269</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32015508</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002622 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002622 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    LockdownV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32434058
   |texte=   A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32434058" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LockdownV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sun Jan 31 08:28:27 2021. Site generation: Sun Jan 31 08:33:49 2021